SCHEMBL14665641

SCHEMBL14665641

COc1ccc(-c2nc3ccc(-c4nc5ccc(-c6nc7ccc(N8CCN(C)CC8)cc7[nH]6)cc5[nH]4)cc3[nH]2)cc1OC

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.78
▸ SMN1; SMN2 Q16637 4/20 0.78
▸ KDM4E B2RXH2 4/20 0.78
▸ MAPT P10636 4/20 0.78
▸ MEN1 O00255 3/20 0.78
▸ KMT2A Q03164 3/20 0.78
▸ BLM P54132 2/20 0.78
▸ GAA P10253 1/20 0.78
▸ RXFP1 Q9HBX9 1/20 0.78
▸ TOP1 P11387 3/20 0.71
▸ TOP2A P11388 3/20 0.71
▸ HPGD P15428 2/20 0.71
▸ HSD17B10 Q99714 1/20 0.71
▸ POLB P06746 2/20 0.70
▸ NPC1 O15118 1/20 0.70
▸ RAB9A P51151 1/20 0.70
▸ SLCO2B1 O94956 1/20 0.67
▸ GLA P06280 1/20 0.67
▸ RECQL P46063 1/20 0.67
▸ BCL2L1 Q07817 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1552158 0.89 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL18007159 0.88 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL14665620 0.88 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL16918643 0.84 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL14091293 0.84 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL16918646 0.84 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL18595033 0.84 SMN1; SMN2 (0.77) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL14399402 0.84 ALDH1A1 (0.80) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
Hoechst 33258 SCHEMBL29376223 0.83 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL14665658 0.83 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9056887-B2 Minor groove binder phosphoramidites and methods of use ELITECH HOLDING B.V. (NL) 2015-06-16 — — US disclosed
US-9056887-B2 Minor groove binder phosphoramidites and methods of use ELITECH HOLDING B.V. (NL) 2015-06-16 — — US disclosed
US-20130030166-A1 MINOR GROOVE BINDER PHOSPHORAMIDITES AND METHODS OF USE ELITECH HOLDING B.V. 2013-01-31 — — US disclosed
US-20130030166-A1 MINOR GROOVE BINDER PHOSPHORAMIDITES AND METHODS OF USE ELITECH HOLDING B.V. 2013-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130030166-A1 MINOR GROOVE BINDER PHOSPHORAMIDITES AND METHODS OF USE PCNA, CD2BP2, BPGM ALDH1A1 3831/4885SMN1; SMN2 3714/4885KDM4E 4345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback